Jennifer Buell - 27 Sep 2023 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Chief Executive Officer
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact for Jennifer S. Buell
Issuer symbol
INKT
Transactions as of
27 Sep 2023
Net transactions value
$0
Form type
4
Filing time
29 Sep 2023, 17:30:09 UTC
Previous filing
11 Jan 2023
Next filing
03 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Options Exercise +695,750 +183% 1,076,465 27 Sep 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INKT Restricted Stock Unit Options Exercise $0 -695,750 -50% $0.000000 695,750 27 Sep 2023 Common Stock 0 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
F2 Represents restricted stock unit convertible into an equivalent number of shares of our common stock, which vested as to 100% of the underlying shares on September 27, 2023.